Advertisements



Lineage Cell Therapeutics conducts sale of shares in OncoCyte

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 11th, 2019

Lineage Cell Therapeutics sells 2.38M OncoCyte shares

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 2nd, 2020

This FDA Approval of Karyopharm’s Lymphoma Treatment Could Be Huge

Karyopharm Therapeutics shares made a handy gain on Wednesday after the firm secured a key FDA nod for its relapsed or refractory diffuse large B-cell lymphoma treatment......»»

Category: blogSource: 247wallstFeb 19th, 2020

Lineage Cell Therapeutics provides update on OpRegen study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 6th, 2020

Lineage Cell Therapeutics provides update on OpRegen study patient enrollment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 30th, 2019

Should You Buy Lineage Cell Therapeutics, Inc. (LCTX)?

Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealin.....»»

Category: topSource: insidermonkeyDec 25th, 2019

Lineage Cell Therapeutics enters into 3 seperate license agreements

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 24th, 2019

Meet the Newest Collaboration in the Fight Against Sickle Cell Disease

Syros Pharma and Global Blood Therapeutics shares were on the move on Wednesday after the companies announced a collaboration to develop and commercialize novel therapies for sickle cell disease and........»»

Category: blogSource: 247wallstDec 18th, 2019

A.G. Edwards, Lineage Cell Therapeutics issued U.S. patent

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 10th, 2019

Why Fate Therapeutics Is One of ASH’s Biggest Winners

Fate Therapeutics shares jumped on Monday after the firm announced new preclinical data for its off-the-shelf, multi-antigen targeting natural killer cell product candidate derived from a clonal........»»

Category: blogSource: 247wallstDec 9th, 2019

Why This Newly FDA Approved Sickle Cell Treatment Will Be Huge

Global Blood Therapeutics shares jumped on Tuesday after the firm announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Oxbryta (voxelotor) tablets for the........»»

Category: blogSource: 247wallstNov 26th, 2019

Global Blood Therapeutics stock is up on sickle cell therapy approval

Shares of Global Blood Therapeutics jumped 11% in pre.....»»

Category: topSource: marketwatchNov 26th, 2019

Lineage Cell Therapeutics provides update on OPC1

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 15th, 2019

Lineage Cell Therapeutics, Inc. (LCTX) CEO Brian Culley on Q3 2019 Results - Earnings Call Transcript

Lineage Cell Therapeutics, Inc. (LCTX) CEO Brian Culley on Q3 2019 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaNov 12th, 2019

Lineage Cell Therapeutics reports Q3 EPS (11c), consensus (5c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 12th, 2019

OpRegen: The Great Asset Of Lineage Cell Therapeutics

OpRegen: The Great Asset Of Lineage Cell Therapeutics.....»»

Category: topSource: seekingalphaOct 19th, 2019

Lineage Cell Therapeutics provides update on Renevia commercialization plans

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 25th, 2019

Lineage Cell Therapeutics receives CE Mark approval for Renevia

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 19th, 2019

Lineage Cell says not planning to conduct additional sales of OncoCyte in NT

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 11th, 2019

Lineage Cell Therapeutics (LCTX ) Presents At H.C. Wainwright 21st Annual Global Investment Conference - Slideshow

Lineage Cell Therapeutics (LCTX ) Presents At H.C. Wainwright 21st Annual Global Investment Conference - Slideshow.....»»

Category: topSource: seekingalphaSep 10th, 2019

Lineage Cell Therapeutics issued U.S. patent

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 4th, 2019